Effect of analogs and antagonists of the thrombocyte-activating factor (PAF) on blood platelet aggregation
Lakin, K.M.; Kulikov, V.I.; Manevich, E.M.; Muliar, A.G.; Shvets, V.I.
Farmakologiia i Toksikologiia 51(4): 113-123
1988
ISSN/ISBN: 0014-8318 PMID: 2847936 Document Number: 308273
Document emailed within 1 workday
Related Documents
Dillingham, E.O.; Lasslo, A.; Gollamudi, R.; Bond, S.E.; Carter-Burks, G. 1990: The effect of carbamoylpiperidine and nipecotoylpiperazine analogs on ADP-stimulated human thrombocyte aggregation and platelet factor 3 availability Research Communications in Chemical Pathology and Pharmacology 67(2): 179-199Macpherson, J.L.; Kemp, A.; Rogers, M.; Mallet, A.I.; Toia, R.F.; Spur, B.; Earl, J.W.; Chesterman, C.N.; Krilis, S.A. 1989: Occurrence of platelet-activating factor (PAF) and an endogenous inhibitor of platelet aggregation in diffuse cutaneous mastocytosis Clinical and Experimental Immunology 77(3): 391-396
Pastorova, V.E.; Umarova, B.A.; Sukhanova, S.A. 1979: Rat thrombocyte factor XIIi and its role in platelet aggregation Biulleten' Eksperimental'noi Biologii i Meditsiny 87(2): 99-101
Muacevic, G.; Heuer, H.O. 1992: Platelet-activating factor antagonists in experimental shock Arzneimittel-Forschung 42(8): 1001-1004
Kertscher, H.P.; Ostermann, G.; Hofmann, B. 1988: Synthesis and thrombocyte-aggregating action of a structural analog of platelet activating factor with a modified head group Die Pharmazie 43(3): 211
Kulikov, V.I.; Muzia, G.I. 1996: Biological role of cellular metabolites--structural analogs of platelet activating factor Biokhimiia 61(3): 387-403
Hwang, S.B.; Li, C.L.; Lam, M.H.; Shen, T.Y. 1985: Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist Laboratory Investigation; a Journal of Technical Methods and Pathology 52(6): 617-630
Issekutz, A.C.; Szpejda, M. 1986: Evidence that platelet activating factor may mediate some acute inflammatory responses. Studies with the platelet-activating factor antagonist, CV3988 Laboratory Investigation; a Journal of Technical Methods and Pathology 54(3): 275-281
Floch, A.; Tahraoui, L.; Sedivy, P.; Cavero, I. 1991: The platelet activating factor receptor antagonist, RP 59227, blocks platelet activating factor receptors mediating liberation of reactive oxygen species in guinea pig macrophages and human polymorphonuclear leukocytes Journal of Pharmacology and Experimental Therapeutics 258(2): 567-575
Shen, T.Y.; Hussaini, I.M. 1990: Kadsurenone and other related lignans as antagonists of platelet-activating factor receptor Methods in Enzymology 187: 446-454
Jäger, W.; Breddin, K.; Krzywanek, H.J.; Stern, A.; Gerlach, U. 1975: Thrombocyte aggregation in healthy subjects and diabetics as examined using photometric platelet aggregation test (PAT III) Verhandlungen der Deutschen Gesellschaft für Innere Medizin 81: 1163-1166
Nechifor, M.; Neughebauer, I.B.; Costuleanu, M.; Alomnicăi, M.; Teslaru, E.; Filip, C.; Cocu, F. 1993: The influence of an PGF2x analogue and of some peptidoleukotrienes and platelet activating factor antagonists in experimentally induced gastric ulcer in rats Romanian Journal of Physiology 30(3-4): 155-159
Yasaka, T.; Boxer, L.A.; Baehner, R.L. 1982: Monocyte aggregation and superoxide anion release in response to formyl-methionyl-leucyl-phenylalanine (FMLP) and platelet-activating factor (PAF) Journal of Immunology 128(5): 1939-1944
Gereliuk, I.P.; Stukal, I.V. 1991: Disorders of plasma lipid spectrum, lysoform levels of platelet activating factor and blood platelet sensitivity to adrenaline in patients with stable stress-induced stenocardia Kardiologiia 31(1): 82-83
Seguchi, M.; Nakajima, S. 1995: Induction of ICAM-1 expression on the eosinophilic leukemia cell line-3 (EoL-3) by platelet-activating factor and platelet factor 4 Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 74(3): 255-257
Moreno, P.; Gijon, M.A.; Fradera, R.; Fabregat, J.; Rafecas, A.; Biondo, S.; Figueras, J.; Sánchez-Crespo, M.; Jaurrieta, E. 1993: Changes in peripheral blood levels of platelet-activating factor after orthotopic liver transplantation Transplantation Proceedings 25(4): 2642-2643
Cheng, D.; Chen, W.; Yang, X. 1996: The level of platelet activating factor in blood of rats with hypoxic pulmonary hypertension Hua Xi Yi Ke da Xue Xue Bao 27(2): 139-142
Sakata, T.; Kobayashi, K.; Katayama, Y.; Takada, T.; Matsuyama, T. 1991: Clinical evaluation of platelet antagonists on the ex vivo inhibitory effects of platelet aggregation Rinsho Byori. Japanese Journal of Clinical Pathology 39(3): 315-320
Ng, D.S.; Wong, K. 1989: Platelet-activating factor (PAF) stimulates phosphatidylinositol hydrolysis in human peripheral blood mononuclear leukocytes Research Communications in Chemical Pathology and Pharmacology 66(2): 219-231
Fradin, A.; Zirrolli, J.A.; Maclouf, J.; Vausbinder, L.; Henson, P.M.; Murphy, R.C. 1989: Platelet-activating factor and leukotriene biosynthesis in whole blood. a model for the study of transcellular arachidonate metabolism Journal of Immunology 143(11): 3680-3685